藥學前沿大講堂第256講

題目: English Writing in Biomedical Research for Publications

報告人: 葉冀明教授，澳大利亞皇家墨爾本理工大學

主持人: 黃志纾教授，太阳集团1088vip

時間: 2016年9月3日（周六）9:30-12:00

地點: 中山大學東校區行政樓B101

報告人簡介:

Prof. Jiming Ye has a research career for over 30 years after his medical training and a Master degree in China. He obtained his PhD degree in the University of Tasmania in Australia with Prof Michael Clark in vascular control of energy metabolism. He was a NHMRC Senior Research Officer with Prof Edward Kraegen at Garvan Institute (Australia) between 1997 and 2003. After one year of clinical trials in Eli Lilly, he returned to Garvan Institute in 2005 leading the research of drug discovery for diabetes and was a conjoint Assoc Prof of the University of NSW (2008-2013). In 2010, he joined RMIT University as an Assoc Prof and established the Molecular Pharmacology for Diabetes Laboratory. Since 2012, he has been a Professor for Ageing and Chronic Disease Management. Prof Ye’s research focuses on two fundamental areas in Type 2 diabetes and fatty liver disease: molecular mechanisms of these metabolic disorders and novel therapeutic approaches for the related diseases. His investigation of the molecular mechanisms focuses on the roles of fatty acid oxidation and synthesis, mitochondrial dysfunction, ER stress and autophagy in the development of insulin resistance and fatty liver disease. Based on identified targets (incl. AMPK, SIRT, FoxO1, HSP72 and epigenetic regulations), his lab conducts research in drug discovery and molecular pharmacology for type 2 diabetes and fatty liver disease. Prof Ye has published >90 peer-reviewed research papers > 4600 total citations and 4 patents. He has expertise in insulin resistant cell/animal models, tracer techniques, biochemical assays, signalling pathways and gene expression for metabolic studies. His current research interests include: 1) Nutrition compositions and metabolic disease, 2) Type 2 diabetes, lipid biology and insulin resistance, 3) Mitochondrial dysfunction, ER stress and autophagy, 4) Metabolic memory and epigenetic regulation, and 5) Drug discovery and molecular pharmacology. Currently, Prof Ye is the Director of the Metabolism, Exercise and Disease Program of 18 research groups. He also leads RMIT’s collaborations with Sun Yat-sen University, Shanghai Institute of Materia Medica and South China University of Technology.

歡迎廣大師生踴躍參與！